Upregulated IGF2BP2 is significantly correlated with weak prognosis, providing a hopeful predictor for pancreatic cancer [43], colorectal cancer [69, 80, 81], osteosarcoma [71], and lung adenocarcinoma [99]. Here, IGF2BP2 is linked to osteosarcoma.